Review
Nature Reviews Genetics 8, 286-298 (April 2007) | doi:10.1038/nrg2005
Focus on: Epigenetics
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller1 About the author
Abstract
An altered pattern of epigenetic modifications is central to many common human diseases, including cancer. Many studies have explored the mosaic patterns of DNA methylation and histone modification in cancer cells on a gene-by-gene basis; among their results has been the seminal finding of transcriptional silencing of tumour-suppressor genes by CpG-island-promoter hypermethylation. However, recent technological advances are now allowing cancer epigenetics to be studied genome-wide — an approach that has already begun to provide both biological insight and new avenues for translational research. It is time to 'upgrade' cancer epigenetics research and put together an ambitious plan to tackle the many unanswered questions in this field using epigenomics approaches.
- View At a Glance
Author affiliations
-
Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
Email: mesteller@cnio.es
Published online 6 March 2007
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The human promoter methylomeNature Genetics News and Views (01 Apr 2007)
Toward a human epigenomeNature Genetics News and Views (01 Dec 2006)
RESEARCH
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics Article (01 Apr 2005)
See all 28 matches for Research
